A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab Article Early Access

Industry Collaboration International Collaboration

cited authors

  • Hummel, Matthew; Bosje, Tjerk; Shaw, Andrew; Liu, Mark Shiyao; Barve, Abhijit; Kothekar, Mudgal; Socinski, Mark A.; Waller, Cornelius F.

authors

Publication Date

  • April 17, 2021

webpage

published in

category

keywords

  • Bioequivalence
  • Cancer
  • Monoclonal antibody
  • Pharmacokinetics
  • Phase 1